Back to PRICE T ROWE ASSOCIATES INC /MD/ PRICE T ROWE ASSOCIATES INC /MD/

ENOVENOV
17 quarters

Position history for PRICE T ROWE ASSOCIATES INC /MD/PRICE T ROWE ASSOCIATES INC /MD/'s holdings in ENOVIS CORP

Yes. Price T Rowe Associates holds 79,418 shares of ENOV (Enovis), worth $1.6M, as of its Q2 2026 13F filing. It increased the position by 9,743 shares (+14.0%) from Q1 2026. Price T Rowe Associates has held ENOV since Q2 2022, across 17 quarterly 13F filings.

Current Value

$1.6M

Current Shares

79,418

Total Value Change

-$331.6M

Total Shares Change

-6M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
79,418
+14.0%
$1.6M0.0%$20.70
29
2026-Q1
Increased
69,675
+21.3%
$1.6M0.0%$22.75
31
2025-Q4
Increased
57,444
+4.6%
$1.5M0.0%$26.64
27
2025-Q3
Increased
54,909
+14.5%
$1.7M0.0%$30.34
29
2025-Q2
Increased
47,958
+21.8%
$1.5M0.0%$31.36
31
2025-Q1
Increased
39,376
+1.6%
$1.5M0.0%$38.21
26
2024-Q4
Decreased
38,750
-84.7%
$1.7M0.0%$43.88
0
2024-Q3
Decreased
252,753
-31.9%
$10.9M0.0%$43.05
0
2024-Q2
Decreased
371,148
-2.6%
$16.8M0.0%$45.20
0
2024-Q1
Increased
381,118
+88.8%
$23.8M0.0%$62.45
45
2023-Q4
Increased
201,842
+587.1%
$11.3M0.0%$56.02
45
2023-Q3
Increased
29,374
+8.7%
$1.5M0.0%$52.73
28
2023-Q2
Decreased
27,030
-12.5%
$1.7M0.0%$64.12
0
2023-Q1
Decreased
30,877
-26.9%
$1.7M0.0%$53.49
0
2022-Q4
Increased
42,240
+8.3%
$2.3M0.0%$53.52
28
2022-Q3
Decreased
38,985
-99.4%
$1.8M0.0%$46.07
0
2022-Q2
New
6.1M
-
$333.2M0.0%$55.00
43

Other major holders of ENOV: BlackRock Finance, Inc., BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used